These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38255960)

  • 1. Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro.
    Dai Y; Xu J; Gong X; Wei J; Gao Y; Chai R; Lu C; Zhao B; Kang Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
    Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
    Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serous Tubal Intraepithelial Carcinoma in a Risk-reducing Salpingo-oophorectomy Specimen From a RAD51D Mutation Carrier: A Case Report.
    Gregory-Davis KJ; Walker A; Colello LS; McKinnon W; Everett E; Chang MC
    Int J Gynecol Pathol; 2023 Jan; 42(1):89-92. PubMed ID: 35149617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.
    Yucer N; Ahdoot R; Workman MJ; Laperle AH; Recouvreux MS; Kurowski K; Naboulsi DJ; Liang V; Qu Y; Plummer JT; Gayther SA; Orsulic S; Karlan BY; Svendsen CN
    Cell Rep; 2021 Dec; 37(13):110146. PubMed ID: 34965417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two different, mutually exclusively distributed,
    Sukhbaatar N; Bachmayr-Heyda A; Auer K; Aust S; Deycmar S; Horvat R; Pils D
    Cold Spring Harb Mol Case Stud; 2017 Jul; 3(4):. PubMed ID: 28679689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.
    Bronder D; Tighe A; Wangsa D; Zong D; Meyer TJ; Wardenaar R; Minshall P; Hirsch D; Heselmeyer-Haddad K; Nelson L; Spierings D; McGrail JC; Cam M; Nussenzweig A; Foijer F; Ried T; Taylor SS
    Dis Model Mech; 2021 Nov; 14(11):. PubMed ID: 34569598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids.
    Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Yao R; Noda T; Itami M; Hippo Y
    J Pathol; 2021 Oct; 255(2):177-189. PubMed ID: 34184756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
    Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
    J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model.
    Blackman A; Rees AC; Bowers RR; Jones CM; Vaena SG; Clark MA; Carter S; Villamor ED; Evans D; Emanuel AJ; Fullbright G; O'Malley MS; Carpenter RL; Long DT; Spruill LS; Romeo MJ; Orr BC; Helke KL; Delaney JR
    Cancer Res Commun; 2024 Sep; 4(9):2525-2538. PubMed ID: 39225558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
    Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
    Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC.
    Xu J; Dai Y; Gao Y; Chai R; Lu C; Yu B; Kang Y; Xu C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
    Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
    Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.
    Hoffmann K; Berger H; Kulbe H; Thillainadarasan S; Mollenkopf HJ; Zemojtel T; Taube E; Darb-Esfahani S; Mangler M; Sehouli J; Chekerov R; Braicu EI; Meyer TF; Kessler M
    EMBO J; 2020 Mar; 39(6):e104013. PubMed ID: 32009247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer.
    Galhenage P; Zhou Y; Perry E; Loc B; Fietz K; Iyer S; Reinhardt F; Da Silva T; Botchkarev V; Chen J; Crum CP; Weinberg RA; Pathania S
    Cell Rep; 2023 Oct; 42(10):113144. PubMed ID: 37729060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer.
    Fransson Å; Glaessgen D; Alfredsson J; Wiman KG; Bajalica-Lagercrantz S; Mohell N
    J Ovarian Res; 2016 May; 9(1):27. PubMed ID: 27179933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Genomic Sequencing Reveals Novel
    Jung YY; Woo HY; Kim HS
    Anticancer Res; 2019 Jun; 39(6):2883-2889. PubMed ID: 31177126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whence High-Grade Serous Ovarian Cancer.
    Kohn EC; Ivy SP
    Am Soc Clin Oncol Educ Book; 2017; 37():443-448. PubMed ID: 28561656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma.
    Lawson BC; Yang RK; Euscher ED; Ramalingam P; Malpica A
    Hum Pathol; 2021 Sep; 115():76-83. PubMed ID: 34153306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.